HDAC6 and pulmonary arterial hypertension: In addition, pharmacological inhibition of HDAC6 by Tubastatin A (TubA) or ACY-775 or siHDAC6 remarkably reduced the proliferation and migration of PAH PASMCs and improved apoptosis resistance.